Monitoring Malaria Treatment In The United States. A Safety Surveillance study
Monitoring Malaria Treatment In The United States. A Safety Surveillance study.
Aims and objectives
This is a US FDA post-marketing commitment study to collect, manage and analyze data on the safety and efficacy of tafenoquine (Krintafel) used for anti-relapse therapy of malaria in the United States.
For more information visit: https://www.cdcfoundation.org/programs/monitoring-malaria-treatment-united-states